23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on using customers’ DNA data to aid in drug discovery.
Struggling 23andMe cuts 40% of workforce in restructuring
The restructuring arrives during a period of turmoil at 23andMe, which has recently included a high-profile data breach and several rounds of previous layoffs.
23andMe Cuts 40% of Its Workforce and Discontinues Therapeutics Division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs
23andMe is laying off 40 percent of its staff
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs will impact 40 percent of the genetic testing company’s workforce. 23andMe CEO and co-founder Anne Wojcicki said in a statement released on Monday that the staff reduction would save the beleaguered company more than $35 million.
23andMe to lay off 40% of its workforce as stock price plummets
The genetic testing company 23andMe is cutting 40% of its workforce and ending its therapeutics program as its stock price continues to plummet. CBS News correspondent Carter Evans has more on what this means for its customers.
23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
23andMe announces layoffs, will cut 40% of workforce
The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile data breach.
23andMe cuts 40% of staff in restructuring
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. “We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
The genetics company is closing a unit that was once seen as core to its future.
CNET on MSN7h
Can I Delete My 23andMe Data? It's Complicated, but Here's How
A big data breach and deepening financial woes have sparked new concerns about the 23andMe's ability to protect the personal ...
newsbytesapp.com21h
DNA-testing site 23andMe is slashing its workforce by 40%
23andMe, a leading name in the genetic testing business, has revealed plans to lay off some ... The breached data ...
South SF-based genetic testing company laying off 40% of workforce
23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...
23andMe users could be eligible for data breach settlement
After a data breach affected around half of its customers, family ancestry company 23andMe has agreed to a $30 million settlement — and users could be eligible to receive a payout in the future.
Yahoo Finance1d
DNA-testing site 23andMe fights for survival
Three years ago, the DNA-testing firm 23andMe was a massive success, with a share price higher than Apple's. But, from those heady days of millions of people rushing to send it saliva samples in ...